Skip to main content
Dual activation of NLRP3 and pyrin inflammasomes mediates host responses to the human fungal pathogen Coccidioides.
Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda.
Potent acridone antimalarial against all three life stages of Plasmodium.
Integrating a host biomarker with a large language model for diagnosis of lower respiratory tract infection.
Characterizing and controlling CRISPR repair outcomes in nondividing human cells.
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort.
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024.
Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis.
Plasma proteomics for biomarker discovery in childhood tuberculosis.
Characterisation of between-cluster heterogeneity in malaria cluster randomised trials to inform future sample size calculations.